Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety [1]

P. E. Levin*, C. W. Colwell, B. Morris, T. E. Spiro, A. A. Trowbridge, H. C. Kwaan, J. D. Blaha, A. J. Comerota, V. Skoutakis

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Fingerprint

Dive into the research topics of 'Use of enoxaparin, a low-molecular-weight heparin, and unfractionated heparin for the prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety [1]'. Together they form a unique fingerprint.